Haemoadapt Live

Name: Haemoadapt
Author: Heart and Brain

Heart and Brain2 apps · 257 installsMedicalFreecom.haemoadapt.app

App for therapeutic decision making in hemophilia A and B

Alert me ★ Watch Open in Play ↗

Total installs: 53
Installs / day: —
Rating: —★
Released: 14 Nov 2024
Last update: 15 Nov 2024
Countries: —

Install history

exact counter from Google Play

30dAll

Installs per day · last 90 days

Change timeline

No changes recorded yet. We compare every crawl with the previous one and list title, icon, screenshots, description, version, price and availability changes here.

Country availability

Availability has not been checked for this app yet. “Check all countries” looks the app up in about 140 Google Play storefronts and shows where it is live, listed but not installable, or missing — plus any country-specific (custom) store listings.

Top countries

Country data will be available soon.

We estimate where downloads come from using the app’s position in Google Play’s top charts in about 140 countries. This app is not in any chart we have collected yet; the estimate appears as soon as it is.

Top chart positions

Not in any tracked top chart.

Inspect the APK

Have this app's APK or XAPK file? Upload it to see the ad & analytics SDKs it bundles, a hidden home-screen launcher or accessibility access, the AdMob app id, and the full permission list — read straight from the file, nothing installed. Bring the file from your device or a mirror; we never fetch it from Google Play.

Permissions

1 in 1 group

0 Sensitive0 Notable1 Routine

OtherRoutine1

Access to miscellaneous device features that don't fit other categories

Connect to the internet to load content and send datafull network access · INTERNET

Sensitive = can reach personal data, location, camera/mic or act on your behalf. Notable = changes how your device behaves. Routine = normal for almost every app. Source: Google Play's permission list for all versions of this app.

Store listing

Full description

HaemoAdapt es una aplicación de asistencia a la toma de decisiones en cuanto a la elección de la terapia más apropiada en hemofilia A y B para cada paciente individual desarrollada por con un prestigioso equipo médico especializado en hematología, basada en el la publicación BloodReviews de 2022 (BloodReviews 52 (2022) 100890) conel aval científico de la Real Fundación Victoria Eugenia y la colaboración de Novo Nordisk España.

What's new

App para toma de decisiones terapéuticas en hemofilia A y B

Growing in Medical

Category →